Anti-CCL4L2/ AT744.2/ CCL4L functional antibody

Anti-CCL4L2/ AT744.2/ CCL4L functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to CCL4L2/CCL4L2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0750-Ab-1/ GM-Tg-hg-SE0750-Ab-2Anti-Human CCL4L2 monoclonal antibodyHuman
GM-Tg-rg-SE0750-Ab-1/ GM-Tg-rg-SE0750-Ab-2Anti-Rat CCL4L2 monoclonal antibodyRat
GM-Tg-mg-SE0750-Ab-1/ GM-Tg-mg-SE0750-Ab-2Anti-Mouse CCL4L2 monoclonal antibodyMouse
GM-Tg-cynog-SE0750-Ab-1/ GM-Tg-cynog-SE0750-Ab-2Anti-Cynomolgus/ Rhesus macaque CCL4L2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0750-Ab-1/ GM-Tg-felg-SE0750-Ab-2Anti-Feline CCL4L2 monoclonal antibodyFeline
GM-Tg-cang-SE0750-Ab-1/ GM-Tg-cang-SE0750-Ab-2Anti-Canine CCL4L2 monoclonal antibodyCanine
GM-Tg-bovg-SE0750-Ab-1/ GM-Tg-bovg-SE0750-Ab-2Anti-Bovine CCL4L2 monoclonal antibodyBovine
GM-Tg-equg-SE0750-Ab-1/ GM-Tg-equg-SE0750-Ab-2Anti-Equine CCL4L2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0750-Ab-1/ GM-Tg-hg-SE0750-Ab-2; GM-Tg-rg-SE0750-Ab-1/ GM-Tg-rg-SE0750-Ab-2;
GM-Tg-mg-SE0750-Ab-1/ GM-Tg-mg-SE0750-Ab-2; GM-Tg-cynog-SE0750-Ab-1/ GM-Tg-cynog-SE0750-Ab-2;
GM-Tg-felg-SE0750-Ab-1/ GM-Tg-felg-SE0750-Ab-2; GM-Tg-cang-SE0750-Ab-1/ GM-Tg-cang-SE0750-Ab-2;
GM-Tg-bovg-SE0750-Ab-1/ GM-Tg-bovg-SE0750-Ab-2; GM-Tg-equg-SE0750-Ab-1/ GM-Tg-equg-SE0750-Ab-2
Products NameAnti-CCL4L2 monoclonal antibody
Formatmab
Target NameCCL4L2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-CCL4L2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0750-Ag-1Recombinant multi-species CCL4L2/ AT744.2/ CCL4L protein


    Target information

    Target IDGM-SE0750
    Target NameCCL4L2
    Gene ID9560
    Gene Symbol and SynonymsAT744.2,CCL4L,CCL4L2,SCYA4L,SCYQ4L2
    Uniprot AccessionN/A
    Uniprot Entry Name
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000276070
    Target ClassificationN/A

    The target: CCL4L2, gene name: CCL4L2, also named as AT744.2, CCL4L, SCYA4L, SCYQ4L2. This gene is one of several cytokine genes that are clustered on the q-arm of chromosome 17. Cytokines are a family of secreted proteins that function in inflammatory and immunoregulatory processes. The protein encoded by this family member is similar to the chemokine (C-C motif) ligand 4 product, which inhibits HIV entry by binding to the cellular receptor CCR5. The copy number of this gene varies among individuals, where most individuals have one to five copies. This gene copy contains a non-consensus splice acceptor site at the 3' terminal exon found in other highly similar gene copies, and it thus uses other alternative splice sites for the 3' terminal exon, resulting in multiple transcript variants. [provided by RefSeq, Apr 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.